20 April 2004
Aicardi syndrome
Ilona Kopyta, Elżbieta Marszał, Ewa JamrozCase Rep Clin Pract Rev 2004; 5(null):246-250 :: ID: 12283
Abstract
Background: Aicardi syndrome is a rare , genetically determinated condition. Most of describe in literature patients are female because the syndrome is X-linked. The Xp22.2-Xp22.3 deletion is lethal
for male fetus. The diagnosis of Aicardi syndrome is usualy established between the age of 3 to 5 months of child’s life; the characteristic features of the syndrome are: female sex (extremely
rare the syndrome occurs in 47,XXY males), infantile spasms, lacunar chorioretinopathy, partial or complete agenesis of corpus callosum. Moreover: central nervous system, eyes and vertebrocostal malformations, psychomotor retardation, typical eeg tracing (“split-brain” EEG) are present.Case Report: The authors present two girls with clinical features of Aicardi syndrome. In both ceses we observed characteristic phenotypic features, developmental delay, seizures (mioclonic, infantile spasms, tonic, partial motor), eyes, costovertebral and CNS malformations (agenesis of corpus callosum and others). As we administered anti-epileptic treatment we reached the reduction of number of seizures. In spite of rehabilitation psychomotor development of our patients is still delayed.Conclusions: The epileptic seizures (mioclonic at onset, then infantile spasms , tonic and partial) at the age between 3 – 5 months of child’s life in a girl with dysmorphic features and malformations of brain, eyes and/or bones suggests the diagnosis of Aicardi syndrome. The prognosis varies depending upon the efected child’s overall health, but is unfavourable as to psychomotor development and antiepileptic treatment efficacy. As Aicardi syndrome may be associated withmalignant neoplasms the patients should be under thorough observation.
Keywords: Aicardi syndrome, corpus callosum agenesis, eyes malformations, infantile spasms
250
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947099
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946151
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946630
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946954
Most Viewed Current Articles
21 Jun 2024 : Case report
93,594
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,205
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
28,023
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,997
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030